EVELIN KEULTJES: Open Payments
NPI 1699322446 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,897 in 92 payments from 19 companies in 2025. Trend: 2023 $1,074 · 2024 $893 · 2025 $1,897
Food & beverage: $1,830Education: $67
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $358 |
| ABBVIE INC. | 28 | $250 |
| Regeneron Healthcare Solutions, Inc. | 5 | $201 |
| GENZYME CORPORATION | 5 | $196 |
| UCB, Inc. | 9 | $174 |
| Mallinckrodt Hospital Products Inc. | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 7 | $117 |
| Incyte Corporation | 3 | $85 |
| Genentech USA, Inc. | 2 | $59 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $57 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, RINVOQ, SKYRIZI, ACTHAR, OPZELURA, Xolair.
Industry payments across IN — which companies pay providers there.
